Panacea Biotec quarterly results and financials

Panacea Biotec (PANACEABIO)₹360.65+1.32%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Panacea Biotec reported sales of ₹200 Cr, up 19.5% from Jun 2025, and net profit of ₹2.21 Cr, down 44.3% year on year. For the year to Mar 2026, sales were ₹641 Cr and net profit −₹7.02 Cr.

Sales (Jun 2026): ₹200 Cr
Net profit (Jun 2026): ₹2.21 Cr
Sales (FY Mar 2026): ₹641 Cr
Net profit (FY Mar 2026): −₹7.02 Cr
EPS (Jun 2026): ₹0.37
Borrowings (Mar 2026): ₹23.93 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Panacea Biotec quarterly results

₹ crore unless stated; each column is a quarter.

Panacea Biotec Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	143	151	137	116	148	164	133	167	141	166	167	200
Expenses	146	150	142	129	140	155	159	168	159	153	164	194
Operating Profit	−3.57	−0.16	−6.06	−14.04	7.03	7.99	−26.99	−1.19	−17.84	11.78	2.58	5.69
OPM %	−2.5%	−0.1%	−4.4%	−12.1%	4.7%	4.9%	−20.3%	−0.7%	−12.6%	7.1%	1.6%	2.8%
Other Income	5.98	8.44	13.52	6.53	7.40	6.37	36.17	16.95	9.08	5.04	5.25	6.96
Interest	0.92	0.86	0.81	0.86	0.97	1.00	1.05	0.85	2.13	1.86	1.19	1.19
Depreciation	9.30	9.10	8.80	8.72	8.67	8.96	8.40	8.37	8.32	8.43	7.87	7.88
Profit before tax	−7.79	−1.66	−2.11	−17.04	4.75	4.37	−0.03	6.57	−19.18	6.50	−1.24	3.58
Tax %	6.5%	33.3%	−6.2%	−6.9%	1.0%	−1.4%	4,875.0%	39.6%	−27.0%	40.0%	−20.0%	38.4%
Exceptional items	2.99	1.99	2.99	2.99	2.99	2.99	25.93	8.97	2.99	1.99	1.99	1.99
Net Profit	−8.31	−2.21	−2.00	−15.91	4.72	4.45	−2.00	3.97	−14.05	3.90	−1.01	2.21
EPS (Rs)	−1.34	−0.36	−0.31	−2.57	0.77	0.73	−0.30	0.65	−2.26	0.64	0.07	0.37

Panacea Biotec profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Panacea Biotec Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	655	545	594	458	545	626	662	461	560	559	641	674
Expenses	540	504	508	590	483	547	673	557	578	583	642	669
Operating Profit	112	39.14	84.24	−134	60.19	77.30	−13.04	−98.38	−20.08	−25.10	−5.02	2.21
OPM %	17.0%	7.0%	14.0%	−29.0%	11.0%	12.0%	−2.0%	−21.0%	−3.5%	−4.4%	−0.7%	0.3%
Other Income	69.83	61.87	7.98	337	−20.95	8.98	1,683	154	61.87	54.80	35.92	26.33
Interest	127	101	101	105	174	185	181	4.01	3.99	4.01	5.99	6.37
Depreciation	72.93	67.84	56.89	53.94	42.95	45.92	43.90	38.94	36.95	34.93	32.96	32.50
Profit before tax	−19.01	−67.08	−66.07	45.05	−178	−146	1,449	13.01	0.99	−7.99	−6.99	−10.34
Tax %	9.9%	−16.0%	15.0%	16.9%	9.0%	1.0%	26.0%	363.0%	200.9%	10.0%	−3.0%	—
Exceptional items	47.85	7.98	0.00	325	−33.92	0.00	1,271	60.82	32.92	33.91	18.96	8.96
Net Profit	−21.05	−56.10	−76.22	38.11	−194	−148	1,081	−34.05	−2.01	−9.02	−7.02	−8.95
EPS (Rs)	−2.97	−8.86	−12.03	6.13	−31.59	−24.03	175.46	−5.40	−0.18	−1.36	−0.87	−1.18
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Panacea Biotec balance sheet

₹ crore, at each year end.

Panacea Biotec Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6.02	6.02	6.02	6.02	6.02	6.01	6.02	6.01	6.01	6.01	6.01	6.01
Reserves	451	428	352	304	345	194	−235	875	840	839	833	833
Borrowings	1,111	1,105	992	941	646	741	819	33.89	19.94	20.91	21.92	23.93
Other Liabilities	366	319	442	351	381	451	590	845	406	377	431	402
Total Liabilities	1,934	1,857	1,791	1,601	1,379	1,392	1,180	1,760	1,273	1,242	1,292	1,264
Fixed Assets	1,149	1,075	1,004	952	809	659	611	624	602	584	569	622
CWIP	155	161	29.92	39.88	22.95	23.95	33.92	16.95	41.90	102	128	99.72
Investments	14.98	8.98	6.99	6.99	4.99	5.99	0.00	4.99	12.98	39.92	2.99	9.98
Other Assets	615	613	749	602	542	703	533	1,113	615	516	592	531
Inventories	310	305	316	334	80.99	148	174	213	202	178	214	193
Trade receivables	98.81	142	142	136	88.79	68.89	84.83	81.86	59.83	56.85	72.78	73.85
Cash & equivalents	51.81	22.95	13.95	22.91	22.92	89.79	136	581	225	139	107	63.81
Total Assets	1,934	1,857	1,791	1,601	1,379	1,392	1,180	1,760	1,273	1,242	1,292	1,264

Panacea Biotec cash flow

₹ crore, for each year.

Panacea Biotec Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	37.07	91.18	131	118	105	−30.03	107	−108	−422	0.00	−27.03	17.02
Cash from investing activity	−36.94	15.96	−25.95	54.88	−5.99	−34.96	−47.90	1,279	429	9.97	64.88	−39.91
Cash from financing activity	−0.99	−117	−107	−164	−101	90.74	−46.85	−1,174	−17.95	−2.99	−2.99	−0.99
Net cash flow	−0.99	−9.98	−1.99	8.98	−1.99	25.93	11.97	−1.99	−9.98	6.98	34.92	−24.94
Capex	8.01	11.02	24.02	15.01	5.01	7.01	22.03	13.03	41.03	78.13	50.07	54.06
Free cash flow	29.96	84.85	107	103	99.95	−20.99	88.85	−119	−424	−70.95	−76.89	−36.97
CFO / OP %	96.1%	64.1%	320.1%	146.1%	−76.9%	−35.9%	141.1%	−2,235.0%	429.1%	−11.9%	108.1%	−495.9%

Panacea Biotec ratios

Working-capital days and returns, by year.

Panacea Biotec Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	51	78	94	83	70	45	48	44	47	36	46	41
Inventory days	404	516	770	651	173	344	311	296	292	282	391	251
Days payable	271	317	606	539	571	462	439	326	255	243	412	246
Cash conversion cycle	183	277	258	194	−329	−74	−81	13	82	75	24	45
Working capital days	−126	27	−46	−96	−363	93	−43	−229	−5	−2	44	57
ROCE %	0.0%	4.0%	2.0%	3.0%	−16.0%	5.0%	5.0%	−6.0%	−10.0%	−4.0%	−5.0%	−2.0%

Panacea Biotec: frequently asked questions

What are the latest quarterly results of Panacea Biotec?

For the Jun 2026 quarter, Panacea Biotec reported sales of ₹200 Cr, up 19.5% year on year and net profit of ₹2.21 Cr, down 44.3% year on year. The operating margin was 2.8%.

What is the annual revenue of Panacea Biotec?

Panacea Biotec's sales for the year to Mar 2026 were ₹641 Cr; over the last twelve months they were ₹674 Cr.

What is the net profit of Panacea Biotec?

Net profit for the year to Mar 2026 was −₹7.02 Cr, and −₹8.95 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−1.18.

How much debt does Panacea Biotec have?

Panacea Biotec reported borrowings of ₹23.93 Cr at Mar 2026, against cash and equivalents of ₹63.81 Cr.

What is the free cash flow of Panacea Biotec?

Cash from operations was ₹17.02 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹36.97 Cr.

Loading…